The Scientific World Journal / 2014 / Article / Tab 1

Review Article

Solid Tumor-Targeting Theranostic Polymer Nanoparticle in Nuclear Medicinal Fields

Table 1

Representative radionuclides used for imaging and radiotherapy.

RadionuclideEmission typeHalf-lifeUsage1

11Cβ + (99.8%), γ (0.2%)20.39 minI
13Nβ + (99.8%), γ (0.2%)9.965 minI
15Oβ + (99.9%), γ (0.1%)2.037 minI
18Fβ + (96.7%), γ (3.3%)109.8 minI
32Pβ (100%)14.24 dayT
64Cuβ + (17.4%), γ (43.6%), 12.70 hT/I
β (39.0%)
89Srβ (100%)50.53 dayT
90Yβ (100%)64.00 hT
99mTcγ (>99.9%)6.015 hT/I
111Inγ (100%)2.805 dayT/I
123Iγ (100%)13.22 hI
125Iγ (100%)59.40 dayT/I
131Iβ8.021 dayT/I
186Reβ, γ3.718 dayT/I
188Reβ, γ17.00 hT
211Atα7.214 hT
213Biα2.14 minT
225Acα10.0 dayT

Radionuclide usage for imaging and therapy are abbreviated as “I” and “T,” respectively.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.